These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 33270750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L, Moiola CP, Masia N, Martinez-Garcia E, Santacana M, Stirbat TV, Brochard-Wyart F, García Á, Alameda F, Cabrera S, Palacios J, Moreno-Bueno G, Abal M, Thomas W, Dufour S, Matias-Guiu X, Santamaria A, Reventos J, Gil-Moreno A, Colas E.
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [Abstract] [Full Text] [Related]

  • 3. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S, Müller V, Köhler N, Wikman H, Krenkel S, Streichert T, Schweizer M, Riethdorf S, Assmann V, Ihnen M, Beck K, Issa R, Jänicke F, Pantel K, Milde-Langosch K.
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [Abstract] [Full Text] [Related]

  • 4. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.
    Cancer Res; 2005 Oct 01; 65(19):8801-8. PubMed ID: 16204050
    [Abstract] [Full Text] [Related]

  • 5. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
    Liang S, Huang C, Jia S, Wang B.
    Int J Gynecol Cancer; 2011 Apr 01; 21(3):523-8. PubMed ID: 21430457
    [Abstract] [Full Text] [Related]

  • 6. Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion.
    Jezierska A, Olszewski WP, Pietruszkiewicz J, Olszewski W, Matysiak W, Motyl T.
    Med Sci Monit; 2006 Jul 01; 12(7):BR245-56. PubMed ID: 16810131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
    Ferragut F, Cagnoni AJ, Colombo LL, Sánchez Terrero C, Wolfenstein-Todel C, Troncoso MF, Vanzulli SI, Rabinovich GA, Mariño KV, Elola MT.
    Biochim Biophys Acta Mol Cell Res; 2019 Aug 01; 1866(8):1338-1352. PubMed ID: 30905597
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway.
    Yang Y, Ma Y, Gao H, Peng T, Shi H, Tang Y, Li H, Chen L, Hu K, Han A.
    Oncogene; 2021 Jan 01; 40(4):731-745. PubMed ID: 33239755
    [Abstract] [Full Text] [Related]

  • 13. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S, Jiang WG.
    Anticancer Res; 2010 Apr 01; 30(4):1163-8. PubMed ID: 20530423
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells.
    Li L, Chen J, Wang Y, Zhou C, Ma X, Fu J, Yao B, Zhao P.
    Toxicology; 2020 Sep 01; 442():152539. PubMed ID: 32681969
    [Abstract] [Full Text] [Related]

  • 15. Sonic Hedgehog Signalling Activation Contributes to ALCAM Over-Expression and Poor Clinical Outcome in Patients with Oral Squamous Cell Carcinoma.
    Chen G, Yan M, Li RR, Chen WT.
    Chin J Dent Res; 2018 Sep 01; 21(1):31-40. PubMed ID: 29507910
    [Abstract] [Full Text] [Related]

  • 16. Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells.
    Darvishi B, Salehi M, Boroumandieh S, Majidzadeh-A K, Jalili N, Moradi-Kalbolandi S, Farahmand L.
    Cell Biochem Funct; 2020 Jul 01; 38(5):651-659. PubMed ID: 32196701
    [Abstract] [Full Text] [Related]

  • 17. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.
    Kijima N, Hosen N, Kagawa N, Hashimoto N, Nakano A, Fujimoto Y, Kinoshita M, Sugiyama H, Yoshimine T.
    Neuro Oncol; 2012 Oct 01; 14(10):1254-64. PubMed ID: 22166264
    [Abstract] [Full Text] [Related]

  • 18. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients.
    Sawhney M, Matta A, Macha MA, Kaur J, DattaGupta S, Shukla NK, Ralhan R.
    Int J Cancer; 2009 May 01; 124(9):2098-105. PubMed ID: 19142865
    [Abstract] [Full Text] [Related]

  • 19. Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
    Curis C, Percher F, Jeannin P, Montange T, Chevalier SA, Seilhean D, Cartier L, Couraud PO, Gout O, Gessain A, Ceccaldi PE, Afonso PV.
    J Virol; 2016 Aug 15; 90(16):7303-7312. PubMed ID: 27252538
    [Abstract] [Full Text] [Related]

  • 20. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
    Clauditz TS, von Rheinbaben K, Lebok P, Minner S, Tachezy M, Borgmann K, Knecht R, Sauter G, Wilczak W, Blessmann M, Münscher A.
    Pathol Res Pract; 2014 Oct 15; 210(10):649-55. PubMed ID: 25028217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.